Literature DB >> 11683498

HMG-17 is an early marker of inductive interactions in the developing mouse kidney.

S Lehtonen1, E Lehtonen.   

Abstract

We studied the relationship between proliferation, differentiation, and the expression of high-mobility-group protein 17 (HMG-17) during metanephric kidney development. Proliferating cells were found homogenously throughout the early kidney rudiment. The expression pattern of HMG-17 mRNA, on the other hand, was distinctly uneven: In the undifferentiated mesenchyme, the cells in the cranial "tail" part of the mesenchyme showed only a weak signal, whereas a group of cells lying close to the tip of the ureteric bud showed strong HMG-17 expression. The region distinctly positive for HMG-17 is known to contain the first cells to undergo mesenchyme-to-epithelium transition. Using the transfilter model system, strong expression of HMG-17 mRNA, followed by mesenchyme-to-epithelium transition, could be induced also in the "tail" part of the mesenchyme. The upregulation of HMG-17 in the metanephrogenic mesenchyme thus results from interaction with an inductor tissue. Throughout the renal development, the HMG-17 mRNA was also abundant in those epithelial and mesenchymal cells that were undergoing active cell differentiation, and the transcript was downregulated in mature cells. HMG-17 expression thus correlated with the processes of induction and differentiation rather than with proliferation. The present results suggest that HMG-17 could have a role in the activation of the genes regulating kidney organogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11683498     DOI: 10.1046/j.1432-0436.2001.670407.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  12 in total

1.  Downregulation of the nucleosome-binding protein 1 (NSBP1) gene can inhibit the in vitro and in vivo proliferation of prostate cancer cells.

Authors:  Ning Jiang; Li-Qun Zhou; Xiao-Yu Zhang
Journal:  Asian J Androl       Date:  2010-06-07       Impact factor: 3.285

Review 2.  HMG chromosomal proteins in development and disease.

Authors:  Robert Hock; Takashi Furusawa; Tetsuya Ueda; Michael Bustin
Journal:  Trends Cell Biol       Date:  2006-12-13       Impact factor: 20.808

3.  Down-regulation of nucleosomal binding protein HMGN1 expression during embryogenesis modulates Sox9 expression in chondrocytes.

Authors:  Takashi Furusawa; Jae-Hwan Lim; Frédéric Catez; Yehudit Birger; Susan Mackem; Michael Bustin
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

Review 4.  Developmental function of HMGN proteins.

Authors:  Takashi Furusawa; Srujana Cherukuri
Journal:  Biochim Biophys Acta       Date:  2010 Jan-Feb

5.  Chromosomal proteins HMGN3a and HMGN3b regulate the expression of glycine transporter 1.

Authors:  Katherine L West; Meryl A Castellini; Melinda K Duncan; Michael Bustin
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

Review 6.  Regulation of chromatin structure and function by HMGN proteins.

Authors:  Yuri Postnikov; Michael Bustin
Journal:  Biochim Biophys Acta       Date:  2009-11-27

Review 7.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

8.  A role for chromosomal protein HMGN1 in corneal maturation.

Authors:  Yehudit Birger; Janine Davis; Takashi Furusawa; Eyal Rand; Joram Piatigorsky; Michael Bustin
Journal:  Differentiation       Date:  2006-02       Impact factor: 3.880

Review 9.  Nuclear functions of the HMG proteins.

Authors:  Raymond Reeves
Journal:  Biochim Biophys Acta       Date:  2009-09-11

10.  An integrated expression profiling reveals target genes of TGF-β and TNF-α possibly mediated by microRNAs in lung cancer cells.

Authors:  Akira Saito; Hiroshi I Suzuki; Masafumi Horie; Mitsuhiro Ohshima; Yasuyuki Morishita; Yoshimitsu Abiko; Takahide Nagase
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.